The Housemaid Worldwide Box Office: Where It Ranks Among Sydney Sweeney’s Last 5 Theatrical Releases

Paul Feig’s The Housemaid has reached approximately $209.2 million worldwide after nearly five weeks in theaters, including over $100 million in North America and an overseas haul approaching $100 million. The film has surpassed Leonardo DiCaprio’s One Battle After Another ($206.3M) and is closing on a top-25 spot for 2025, indicating strong global box-office demand that may lift studio revenue forecasts and ancillary monetization prospects.

Analysis

Market structure: A $209.2M global haul (≈$100M domestic, ≈$100M international) signals continued consumer willingness to pay for theatrical-first adult dramas; primary beneficiaries are exhibitors (box office revenue share), studios with theatrical windows and downstream licensing, and ad-supported/AVOD platforms monetizing post-theatrical windows. Impact on Disney (DIS) is indirect but positive for sector sentiment—expect modest box office-driven EBITDA tailwind for integrated studios and potential 1–3% uplift to exhibitor revenues over the next 2–3 quarters if this performance is replicated across 3–5 titles.

Risk assessment: Tail risks include a steep weekend decay (>50%) or a China/EM distribution block that can erase >30% of upside, and reputational shocks (talent controversy) that can reverse momentum in days. Immediate (days): monitor weekend decay and per-theater averages; short-term (weeks/months): international rollouts and PVOD timing; long-term (quarters/years): sequel/franchise potential and licensing windows driving lifetime value. Hidden dependencies: backend profit participation, awards season lift, and territorial censorship that can swing revenues ±20–40%.

Trade implications: Direct plays—establish a measured 1.5–3% long in DIS (integrated studio exposure) with 3–6 month horizon, target +10–15%, hard stop -7%. Pair trade—long DIS 2% vs short NFLX 1.5% to express theatrical tailwind over pure-streaming; exit on quarterly subscriber/cash-flow divergence. Options—buy 3-month DIS 10–15% OTM call spread sized for 1% notional to cap premium; consider selling short-dated put spreads if implied vol normalizes.

Contrarian angle: Consensus treats single-title wins as sustainable theatrical recovery; history (e.g., 2017–2019 surprise hits) shows limited long-term share shifts without a slate of repeatable hits. If awards/nominations arrive, upside rerating can be rapid; conversely, over-indexed exhibitors (AMC) risk being disappointed if slate thins—avoid concentrated single-name bets and size positions to slate risk.

Key Decisions for Investors

• Establish a 2% long position in DIS (ticker: DIS) with a 3–6 month horizon, target +10–15% upside and a -7% stop; catalysts: Q1 slate announcements, PVOD/windowing news, awards nominations.
• Implement a pair trade: long DIS 2% vs short NFLX 1.5% to express theatrical-first monetization beating pure SVOD; revisit after next quarterly results or if Netflix reports >1% QoQ ARPU growth.
• Buy a 3-month DIS call spread 10–15% OTM sized to 1% of portfolio notional to capture sequel/ancillary upside while limiting premium; exit if implied vol rises >30% or price hits target.
• Take a small speculative 0.5–1% position in a diversified exhibitor exposure (e.g., AMC/IMAX) via call spreads only; cap downside—add more only if three additional new-release titles each cross $50M global within 60 days.
• Monitor weekly metrics: domestic weekend decay rate (>40% signals fatigue), international release windows (China/UK releases), and award nominations—use any one adverse threshold as stop/trim trigger within 7–30 days.